Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preoperative Extended Chemotherapy vs. Chemotherapy Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Head of the Pancreas

NCT02839343 is registered in ClinicalTrials.gov with Alliance for Clinical Trials in Oncology as lead sponsor.

NCT NCT02839343
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02839343 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preoperative Extended Chemotherapy vs. Chemotherapy Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Head of the Pancreas
Lead sponsor
Alliance for Clinical Trials in Oncology
Phase
Phase 2
Overall status
Unknown status
Start date
December 31, 2016
Completion date
Not reported
Enrollment
126 (actual)
Sites
155

Conditions

As the registry lists them; a condition with its own page is linked.

borderline resectable adenocarcinoma of the head of the pancrease, pancreatic adenocarcinoma